Bio Techne Valuation
| T1CH34 Stock | 13.08 0.36 2.68% |
At this time, the firm appears to be overvalued. Bio Techne shows a prevailing Real Value of USD11.45 per share. The current price of the firm is USD13.08. Our model approximates the value of Bio Techne from analyzing the firm fundamentals such as Profit Margin of 0.23 %, current valuation of 73.29 B, and Return On Equity of 0.15 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bio Techne's price fluctuation is not too volatile at this time. Calculation of the real value of Bio Techne is based on 3 months time horizon. Increasing Bio Techne's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bio Techne is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bio Stock. However, Bio Techne's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 13.08 | Real 11.45 | Hype 13.08 | Naive 11.62 |
The real value of Bio Stock, also known as its intrinsic value, is the underlying worth of Bio Techne Company, which is reflected in its stock price. It is based on Bio Techne's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bio Techne's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bio Techne helps investors to forecast how Bio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bio Techne more accurately as focusing exclusively on Bio Techne's fundamentals will not take into account other important factors: Bio Techne Total Value Analysis
Bio Techne is at this time forecasted to have takeover price of 73.29 B with market capitalization of 60.28 B, debt of 243.41 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bio Techne fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
73.29 B | 60.28 B | 243.41 M |
Bio Techne Investor Information
The company last dividend was issued on the 10th of February 2023. Bio Techne had 1:4 split on the 28th of November 2022. Based on the measurements of operating efficiency obtained from Bio Techne's historical financial statements, Bio Techne is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Bio Techne Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bio Techne has an asset utilization ratio of 48.18 percent. This suggests that the Company is making USD0.48 for each dollar of assets. An increasing asset utilization means that Bio Techne is more efficient with each dollar of assets it utilizes for everyday operations.Bio Techne Profitability Analysis
The company reported the revenue of 1.11 B. Net Income was 272.05 M with profit before overhead, payroll, taxes, and interest of 758.09 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bio Techne's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bio Techne and how it compares across the competition.
About Bio Techne Valuation
The stock valuation mechanism determines Bio Techne's current worth on a weekly basis. Our valuation model uses a comparative analysis of Bio Techne. We calculate exposure to Bio Techne's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bio Techne's related companies.8 Steps to conduct Bio Techne's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bio Techne's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bio Techne's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bio Techne's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bio Techne's revenue streams: Identify Bio Techne's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bio Techne's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bio Techne's growth potential: Evaluate Bio Techne's management, business model, and growth potential.
- Determine Bio Techne's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bio Techne's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Bio Stock analysis
When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |